BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 29388081)

  • 1. Loss of Angelman Syndrome Protein E6AP Disrupts a Novel Antagonistic Estrogen-Retinoic Acid Transcriptional Crosstalk in Neurons.
    El Hokayem J; Weeber E; Nawaz Z
    Mol Neurobiol; 2018 Sep; 55(9):7187-7200. PubMed ID: 29388081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E6-Associated Protein Dependent Estrogen Receptor Regulation of Protein Kinase A Regulatory Subunit R2A Expression in Neuroblastoma.
    Obeid JP; Zeidan YH; Zafar N; El Hokayem J
    Mol Neurobiol; 2018 Feb; 55(2):1714-1724. PubMed ID: 28214999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Angelman syndrome substitution in the HECT E3 ubiquitin ligase C-terminal Lobe of E6AP affects protein stability and activity.
    Beasley SA; Kellum CE; Orlomoski RJ; Idrizi F; Spratt DE
    PLoS One; 2020; 15(7):e0235925. PubMed ID: 32639967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
    Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
    Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.
    LaSalle JM; Reiter LT; Chamberlain SJ
    Epigenomics; 2015 Oct; 7(7):1213-28. PubMed ID: 26585570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein.
    Cooper EM; Hudson AW; Amos J; Wagstaff J; Howley PM
    J Biol Chem; 2004 Sep; 279(39):41208-17. PubMed ID: 15263005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E6AP in the brain: one protein, dual function, multiple diseases.
    El Hokayem J; Nawaz Z
    Mol Neurobiol; 2014 Apr; 49(2):827-39. PubMed ID: 24091829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion.
    Dodge A; Peters MM; Greene HE; Dietrick C; Botelho R; Chung D; Willman J; Nenninger AW; Ciarlone S; Kamath SG; Houdek P; Sumová A; Anderson AE; Dindot SV; Berg EL; O'Geen H; Segal DJ; Silverman JL; Weeber EJ; Nash KR
    Autism Res; 2020 Mar; 13(3):397-409. PubMed ID: 31961493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
    Samaco RC; Hogart A; LaSalle JM
    Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily.
    Nawaz Z; Lonard DM; Smith CL; Lev-Lehman E; Tsai SY; Tsai MJ; O'Malley BW
    Mol Cell Biol; 1999 Feb; 19(2):1182-9. PubMed ID: 9891052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation.
    Condon KH; Ho J; Robinson CG; Hanus C; Ehlers MD
    J Neurosci; 2013 Feb; 33(9):3799-814. PubMed ID: 23447592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions.
    Khatri N; Man HY
    Front Mol Neurosci; 2019; 12():109. PubMed ID: 31114479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants.
    Offensperger F; Müller F; Jansen J; Hammler D; Götz KH; Marx A; Sirois CL; Chamberlain SJ; Stengel F; Scheffner M
    Cell Chem Biol; 2020 Dec; 27(12):1510-1520.e6. PubMed ID: 32966807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angelman syndrome scientific symposium on the structure and function of UBE3A/E6AP.
    Williams C
    J Child Neurol; 2009 Jul; 24(7):904-8. PubMed ID: 19617463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.
    Meng L; Ward AJ; Chun S; Bennett CF; Beaudet AL; Rigo F
    Nature; 2015 Feb; 518(7539):409-12. PubMed ID: 25470045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angelman syndrome-associated point mutations in the Zn
    Kühnle S; Martínez-Noël G; Leclere F; Hayes SD; Harper JW; Howley PM
    J Biol Chem; 2018 Nov; 293(47):18387-18399. PubMed ID: 30257870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons.
    Albrecht U; Sutcliffe JS; Cattanach BM; Beechey CV; Armstrong D; Eichele G; Beaudet AL
    Nat Genet; 1997 Sep; 17(1):75-8. PubMed ID: 9288101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The active form of E6-associated protein (E6AP)/UBE3A ubiquitin ligase is an oligomer.
    Ronchi VP; Klein JM; Edwards DJ; Haas AL
    J Biol Chem; 2014 Jan; 289(2):1033-48. PubMed ID: 24273172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Autism Protein Ube3A/E6AP Remodels Neuronal Dendritic Arborization via Caspase-Dependent Microtubule Destabilization.
    Khatri N; Gilbert JP; Huo Y; Sharaflari R; Nee M; Qiao H; Man HY
    J Neurosci; 2018 Jan; 38(2):363-378. PubMed ID: 29175955
    [No Abstract]   [Full Text] [Related]  

  • 20. UBE3A regulates the transcription of IRF, an antiviral immunity.
    Furumai R; Tamada K; Liu X; Takumi T
    Hum Mol Genet; 2019 Jun; 28(12):1947-1958. PubMed ID: 30690483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.